Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedFrontend revision updated: v3.5.0 deployed and v3.4.3 removed.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.4.3 has been added to the page footer, and the previous label Revision: v3.4.2 has been removed.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added, and Revision: v3.4.1 along with a government funding status notice were removed. These are housekeeping updates that do not affect the study details or trial information.SummaryDifference0.3%

- Check61 days agoChange DetectedIntroduced a government funding lapse notice on the page and updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check68 days agoChange DetectedThe page gains a glossary toggle and updated metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a new revision tag (v3.4.0), while related older metadata items are removed. These changes pertain to navigation/maintenance rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. The new revision is now displayed in place of the previous version.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.